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ABSTRACT 
Pain is a sensation which in many cases represents the only symptom for the diagnosis of several disorders. Throughout ages m an has used 
many different remedies for pain relief, among which medicinal herbs are most common due to their efficacy and relative safety due to their 
natural origin. Iris kashmiriana Baker (I. kashmiriana) is an important member of the family Iridaceae, locally known as Mazarmund in Kashmir 
valley. The plant owes its significance because of its endemic nature to the region and its use in alternative medicine as emetic, cathartic, 
diuretic and expectorant since long time. This study evaluated the antioxidant and antinociceptive effect of the methanolic extract of I. 
kashmiriana rhizomes in mice. Qualitative phytochemical screening of methanolic extract was carried out to identify the phytoconstituents. The 
In vitro antioxidant activity of methanolic extracts of I. kashmiriana rhizomes (IKME) was assessed against reducing power assay using 
standard protocols. The methanolic extract was assessed for antinociceptive activity using chemical and heat induced pain models such as hot 
plate and acetic acid-induced writhing test models in mice at the doses of 100 and 200 mg/kg (p.o.). Morphine sulphate (5mg/kg, i.p.) was used 
as reference analgesic drugs. The phytochemical screening results showed that the extract had flavonoids, steroids, saponins, phenolics and 
terpenoids which have been associated with anti-nociceptive activities. IKME demonstrated potent and dose-dependent antinociceptive activity 
in the chemical and heat induced mice models (p <0.001). Above findings suggest that I. kashmiriana rhizomes extract possesses significant 
antinociceptive activity in albino mice with reference to positive and negative control groups; however further studies on a large number of 
animals with clinical trials are required to confirm safe and effective use of this rhizomes extract in humans for pain purpose. 
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INTRODUCTION 
Herbal drugs are manufactured from fresh or dried plants 
having interrelated compounds that work together. In 
comparison pharmaceutical drugs are solitary compounds 
that are often synthetic in nature. Herbal drug expert treated 
their patient using herbs, food and lifestyles modifications to 
cure through addressing the root cause of illness; however 
modern medicine usually manages only the symptoms of 
diseases with strong compounds that they contain. They 
seldom address the actual cause of ailment. It means that 
herbals treatment follows relatively holistic approach for 
remedial purposes1,2. Ethno-pharmacological research on 
medicinal plants can promote the development of newer and 
safer compounds. These studies may help in the discovery of 
a new drug molecule from the herbal source and hence may 
endorse the use of traditional drugs in humans. Medicinal 
plants have strong historical background as remedy for 
different ailments. Around 25% of our current prescription 
medicines have been originated from medicinal plants. 
These products have been used as medication and dietary 
supplements in both developing and developed countries3. 
In several countries, herbal drugs are still the most common 
available health source for the majority of the population 
and its use has been encouraged by the government 
authorities along with modern medicine4,5. Herbal medicines 
have been investigated under strict control and approved by 
the health authorities of developed countries worldwide. 
They are generally treated as dietary supplement and World 
Health Organization has given separate guidelines to ensure 
their safety and efficacy6,7. However in developing countries, 
herbal medicines are used for the management of various 
disorders and their use is generally accepted in the society 
as alternate system of medicine8,9. Herbal drugs therefore 
have potential for improving general health and lower 
health care cost10. Pain can be defined as a stressful 
sensation in a specific part of the body. International 
Association for the Study of Pain defines it as “an unpleasant 
sensory and emotional experience related with real or 
probable tissue injury”11. Pain encourages the person to 
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avoid bothersome situations, to care for a wounded body 
part until healing and to escape related incidences in future. 
Most pain subsides quickly as the painful stimulus is 
removed and the body has repaired, but sometimes may 
remain regardless of elimination of the stimulus and obvious 
healing of the body part. Occasionally pain begins in the 
absence of any detectable stimulus, injury or disease. 
Generally pain has been classified in three classes: 
nociceptive, inflammatory and pathological pain caused by 
damage to the nervous system or by alteration in its function 
e.g. fibromyalgia, irritable bowel syndrome and tension type 
headache. The pain pathway usually involves transduction, 
transmission, modulation and perception12. Drugs 
commonly in use for pain management and are classified as 
opioids analgesics, non-steroidal anti- inflammatory drugs 
(NSAIDs) and steroidal anti-inflammatory medicines. All 
these medicines have adverse effects e.g. dependence, 
constipation and respiratory problems with opioids13, 
gastrointestinal risk and renal insufficiency with NSAIDs and 
immune system depression, increasing chances of infection 
and decreasing wound healing by steroidal treatment14,15. 
Medicinal plants have been extensively used for a long time 
to avoid these adverse effects. It is necessary to discover 
new plants to come up with naturally safe and effective pain 
killer therapy. Plants exemplify still a large available and 
unexplored source of new chemicals that can help in the 
development of novel analgesic drugs16,17. 
The Iris plant belonging to family Iridaceae is worldwide in 
distribution, the genus comprising of about 300 species 
known for their ornamental relevance and medicinal value. 
The species of the genus Iris are very useful for pulmonary 
asthma, cancer, inflammation, liver and uterus diseases18. 
The intensive phytochemical investigations of various iris 
species have resulted in the isolation of a variety of 
compounds including quinones, triterpenoids, flavonoids, 
isoflavonoids and stilbene glycosides19. Flavonoids and 
isoflavonoids are important plant secondary metabolites 
with structural diversity and are consumed by human as 
dietary constituents20. The isoflavone rich dietary 
consumption is reported to reduce risk of cancer particularly 
breast and prostate cancer21,22. The role of isoflavones in 
cancer23,24 osteoporosis, cardiovascular diseases and 
menopausal symptoms in addition to their antioxidant25 
antimicrobial26 anti-inflammatory and estrogenic 
activities23,27 is well documented. I. kashmiriana is one of an 
important member of this family Iridaceae, locally known as 
Mazarmund in Kashmir. The plant has been widely used in 
traditional medicine and modern clinical preparations to 
treat cold, flu, malaria, toothache, cancer, bacterial and viral 
infections and bruise. The phytochemical analyses of the 
different extracts of I. kashmiriana have revealed the 
presence of different compounds including flavonoids, 
isoflavonoids, glycosides and tannins. The medicinal 
importance of the plant prompted isolation of a variety of 
pharmacologically active compounds including quinones, 
triterpenoids, flavonoids, isoflavonoids and stilbene 
glycosides28. The use of I. kashmiriana in different painful 
conditions in folk medicine but lack of scientific study 
reporting its antinociceptive activity in both chemical- and 
heat-induced nociception models convinced us to design the 
present study to evaluate the antinociceptive effect of 
methanolic extract of the rhizomes of I. kashmiriana. 
MATERIALS AND METHODS 
Plant material  
Rhizomes of I. kashmiriana were collected from Pinnacle 
Biomedical Research Institute (PBRI), Near, Bharat Scout 
and Guides Campus, Shanti Marg, Shyamla Hills Road, Depot 
Chouraha, Bhopal, Madhya Pradesh 462003, India. The 
sample was identified by senior Botanist Dr. Zia-Ul-Hassan, 
Professor and head department of Botany, Safia College of 
Arts and Science, peer gate Bhopal. A herbarium of plants 
was submitted to the specimen library of Safia College of 
Arts and Science, peer gate Bhopal and The specimen 
voucher no. of I. kashmiriana was 112/Bot/Saf/230.  
Chemical reagents 
All the chemicals used in this study were obtained from Hi 
Media Laboratories Pvt. Ltd. (Mumbai, India), Sigma-Aldrich 
Chemical Co. (Milwaukee, WI, USA), SD Fine-Chem. Ltd. 
(Mumbai, India) and SRL Pvt. Ltd. (Mumbai, India).All the 
chemicals used in this study were of analytical grade.  
Extraction  
Dried pulverized rhizomes of I. kashmiriana were placed in 
thimble of soxhlet apparatus. Soxhlation was performed at 
60°C using petroleum ether (40-60ºC) as non-polar solvent 
at first. Exhausted plant material (marc) was dried and then 
extracted with methanol. For each solvent, soxhlation was 
continued till no colour was observed in siphon tube. For 
confirmation of exhausted plant marc (i.e. completion of 
extraction), colorless solvent was collected from siphon tube 
and completion of extraction was confirmed by absence of 
any residual solvent, The entire extract was concentrated to 
dryness using rotary flash evaporator under reduced 
pressure and stored in an air tight container free from any 
contamination until it was used. Finally the percentage 
yields were calculated of the dried extracts28.  
Phytochemical screening 
The crude methanolic extract of I. kashmiriana was 
qualitatively tested for the detection of alkaloids, flavonoids, 
saponins, tannins, glycosides, carbohydrates, reducing 
sugars, proteins, glucosides, terpenoids, and steroids 
following standard procedures29. 
Reducing power assay 
A spectrophotometric method was used for the 
measurement of reducing power. For this 0.5 ml of each of 
the extracts was mixed with 0.5ml phosphate buffer (0.2 M, 
pH 6.6) and 0.5 ml of 1% potassium ferricyanide (10 
mg/ml). The reaction mixture was incubated at 50 ºC for 20 
min separately, and then rapidly cooled, mixed with 1.5 ml 
of 10% trichloroacetic acid and centrifuged at 6500 rpm for 
10 min. An aliquot (0.5ml) of the supernatant was diluted 
with distilled water (0.5ml) and then ferric chloride (0.5ml, 
0.1%) was added and allowed to stand for 10 min. the 
absorbance was read spectrophotometrically at 700 nm. 
Ascorbic acid (AA) was used as standard for construction of 
calibration curve30. Plot a curve of absorbance versus 
concentration. Increased absorbance of the reaction mixture 
indicates increase in reducing power. 
Reducing Power (%) = (As / Ac) × 100 
Here, Ac is the absorbance of control and As is the 
absorbance of samples (extracts) or standards. 
Animals 
All ethical and handling guidelines were followed as set by 
Indian Legislation and approved by Institutional Animal 
Ethics Committee. All animals were procured and housed in 
animal house maintained under standard hygienic 
conditions. Animal experiments were approved by 
Institutional Animal Ethics Committee (IAEC) of Pinnacle 
Biomedical Research Institute (PBRI) Bhopal (Reg No. 
1824/PO/ERe/S/15/CPCSEA). Protocol Approval Reference 
No. PBRI/IAEC/PN- 1808.  
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Acute oral toxicity 
Acute toxicity study of the prepared rhizomes extracts of I. 
kashmiriana was carried out according to the Organization 
for Economic Co-Operation and Development (OECD) 
Guidelines-42331 the animals were fasted for 4 h, but 
allowed free access to water throughout. Nulliparous healthy 
female mice were used for this study. 3 animals per step 
were selected. Dose selected 5, 50, 300, 2000 mg/kg body 
weight. Immediately after administration of extract, all of the 
animals were observed for a total of 14 days based on 
established criteria, observations of behavior pattern 
changes in skin and eye, respiration, tremors, convulsions, 
salivation, diarrhea, lethargy, sleep and coma. With special 
attention given during the first 4 hours, clinical signs or 
mortality were noted. On day 15, all of the animals were 
euthanized by cervical dislocation. Acute toxicity was 
determined as per reported method32. 
Antinociceptive activity test 
Acetic acid-induced writhing test 
To evaluate the analgesic activity of the plant extract acetic 
acid writhing model in mice was conducted accordingly the 
procedure described by Koster et al33. The test samples 
(methanolic extract of I. kashmiriana 100 and 200 mg/kg 
body weight respectively), standard (morphine, 10 mg/kg 
body weight per orally) and control (1% Tween 80 in 
distilled water at the dose of 10 ml/kg body weight) were 
given and after 30 min 0.85% acetic acid was injected intra-
peritoneally (i.p.). The writhing (constriction of abdomen, 
turning of trunk and extension of hind legs) was observed 
randomly after 15 min of interval and its frequency was 
counted for up to 25 min in each group of animals. The 
percent inhibition (% analgesic activity) was calculated by: 
%Inhibition= [(A−B/A)] ×100 
Where, A=Average number of writhing of the control group; 
B =Average number of writhing of the test or standard 
groups. 
Hot plate test 
The hot-plate test was performed according to the method 
described by Eddy and Leimbach (1953)34 with slight 
modification. The temperature of the metal surface of Eddy’s 
hotplate was set at 52±2°C. The mice that showed fore paw 
licking, withdrawal of the paw(s) or jumping response 
within 15s on hotplate were selected for this study 24h prior 
to the experiment. Mice were fasted overnight with water 
given ad libitum. The mice were then treated with 0.9% 
sodium chloride solution as vehicle (0.1 ml/ mice, p.o.), 
HMCR (50, 100, and 200 mg/kg), and morphine as positive 
control (5 mg/kg, i.p.). IKME was administered 
(100 and 200mg/kg p.o.) 30 min before the experiment 
while morphine sulphate was administered (10 mg/kg, i.p.) 
15 min before the experiment. The response in the form of 
fore paw licking, withdrawal of the paw(s) or jumping was 
recorded at 30, 60, 90, and 120 min following treatment. A 
cut off period of 20s was maintained to avoid paw tissue 
damage. The results of the hot plate test are expressed as a 
percentage of the maximal possible effect (%MPE), which 
was calculated using following formula: 
%MPE = [(Postdrug latency-predrug latency)/ (Cut off 
period-predrug latency)] ×100 
RESULTS AND DISCUSSION 
The crude extracts so obtained after the soxhlation process, 
extract were further concentrated on water bath by 
evaporation the solvents completely to obtain the actual 
yield of extraction. The percentage yield of methanolic 
extract was found to be 2.95 %.  Phytochemical analysis of 
methanolic extract of I. kashmiriana rhizomes showed the 
presence of carbohydrate, flavonoids, phenolics, tannin, 
saponins, triterpenoids Table 1. 
Table1 Phytochemical analysis of methanolic rhizomes 
extract of I. kashmiriana 
S. N. Constituents I. kashmiriana 
1. Alkaloids 
Mayer’s reagent test 
Wagner’s reagent test 
Hager’s reagent test 
 
-ve 
-ve 
-ve 
2. Carbohydrates 
Molish’s test 
Fehling’s test 
Benedict’s test 
Barfoed’s test 
 
+ve 
+ve 
+ve 
+ve 
3. Proteins and amino Acids 
Biuret test 
 
+ve 
4. Flavonoids  
Alkaline reagent test 
Lead acetate test 
 
+ve 
+ve 
5. Glycoside  
Borntrager test 
Legal’s test 
Killer-Killiani test 
 
-ve 
-ve 
-ve 
6. Tannin and phenolic 
compounds  
Ferric chloride test 
Lead acetate test 
Gelatin test 
+ve 
+ve 
+ve 
7. Saponin 
Foam test 
 
-ve 
8. Test for triterpenoids and 
steroids  
Salkowski’s test 
Libbermann-Burchard’s test 
+ve 
+ve 
 
Antioxidant activity of the samples was calculated through 
reducing power assay. The reducing ability of the compound 
usually depends on the reductants, which have been 
exhibited antioxidative capacity by breaking the free radical 
chain, donating a hydrogen atom. Reducing power assay was 
calculated in extracts and the values indicated a better 
activity Table 2& Fig. 1. 
 
Table 2 Result of reducing power assay 
S. No. Concentration (µg/ml) Ascorbic acid Methanolic Extract 
1. 20 0.107 0.061 
2. 40 0.122 0.088 
3. 60 0.139 0.102 
4. 80 0.156 0.123 
5. 100 0.182 0.145 
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Fig. 1 Reducing power assay 
Acute oral toxicity was calculated at four different 
concentrations 5mg/kg, 50mg/kg, 300 mg/kg and 2000 
mg/kg. Observations were performed in groups of three and 
no mortality was observed Table 3. The acute toxicity results 
showed that methanolic extracts of I. kashmiriana rhizomes 
was safe up to a dose of 2000 mg/kg body weight. Based on 
acute toxicity data, two different dosages 100 and 200 
mg/kg (p.o.) were selected for in vivo anti-nociceptive 
activity. 
Table 3 Acute oral toxicity 
S. No. Groups 
Observations/ 
Mortality 
1. 5 mg/kg Bodyweight 0/3 
2. 50 mg/kg Bodyweight 0/3 
3. 300 mg/kg Bodyweight 0/3 
4. 2000 mg/kg Bodyweight 0/3 
 
Table 4 shows the antinociceptive effect of IKME and 
standard drug (Morphine) assessed using the hot plate test. 
IKME, at the doses of 100 and 200 mg/kg, exhibited 
significant (p < 0.001) ability to prolong the latency of 
response to thermal-induced nociception throughout the 
whole experimental period. The effect was dose-dependent 
and IKME showed stronger effect at 100 and 200 mg/kg 
doses. The hot-plate test is a specific test carried out to 
verify involvement of central mechanism with 
compounds/drugs showing antinociceptive activity25.In this 
work, HMCR showed a marked inhibition on thermal 
induced hyperalgesia as it showed significant increase in 
latency (p < 0.001) compared to control. Morphine (10 
mg/kg i.p.) was used as a standard drug which 
demonstrated a stronger analgesic effect than IKME. The 
effect was evident from the elongation of the latency time till 
the 4th observation (120min). The effect of compounds or 
plant extract in such mechanism by increasing the latency 
are suggested to act like centrally mediated drugs35 by 
activating the periaqueductal gray matter (PAG) to release 
endogenous peptides (i.e., endorphin or enkephalin). These 
endogenous peptides descend the spinal cord and function 
as inhibitors of the pain impulse transmission at the synapse 
in the dorsal horn36. The acetic acid induced writhing test is 
widely used for antinociceptive screening and involves local 
peritoneal receptors (cholinergic and histamine receptor) as 
well as the mediators of acetylcholine and histamine37. In the 
abdominal tissues acetic acid injection produces peritoneal 
inflammation, which triggers a response characterized by 
writhing. Such types of responses are induced by the release 
of endogenous mediators of pain such as prostaglandins, 
bradykinine and cytokines (TNF-α, IL-1β and IL-8) that 
stimulate the nociceptive neurons, which are sensitive to 
non steroidal anti-inflammatory drugs (NSAIDs) and 
opioids38. In our study, IKME inhibitied the acetic acid 
induced writhing in a dose dependent manner (Table 5). 
These responses can be described as a typical model of 
inflammatory pain in which the sensory neurons are 
depolarized by directly activating a non-selective cationic 
channel of cutaneous, visceral and other types of peripheral 
afferent C fibers39. Thus, the significant reduction in the 
number of acetic acid-induced writings by IKME indicates 
the antinociceptive potential of this plant and confirms its 
traditional use for the relief of inflammatory pain.
 
Table 4 Antinociceptive effect of I. kasmiriana extract and morphine in hot plate test 
Groups Mean latency ± SD 
30 60 90 120 
Control 6.00± 0.816 6.66±0.471 7.00± 0.816 7.66± 0.471 
Morphine 9.00 ± 0.816 10.0±2.94 11.33 ± 1.24 15.33 ± 1.24 
IKME 100 8.00 ± 0.816 8.66±1.24 9.33 ± 0.942 10.66± 0.471 
IKME 200 8.33± 0.417 9.66 ± 1.24 11.00± 0.816 13.33 ± 1.69 
 
Table 5 Antinociceptive effect of methanolic extract of I. kashmiriana on acetic acid writhing test 
Groups Number of writhes 
Mean ± SD 
Control 37.66± 2.05 
Morphine 11.00 ± 1.63 
IKME 100 21.66± 2.05 
IKME 200 28.33 ± 2.86 
 
 
CONCLUSION 
The results of the present study indicate that IKME exhibited 
significant antinociceptive activity at all the tested doses in 
mice. The effect is dose dependent and statistically 
significant particularly at 100 and 200 mg/kg doses. Taking 
these findings into account, it seems quite possible that 
IKME contains constituents with promising antinociceptive 
activity. The traditional use of the plant in the treatment of 
painful conditions can be affirmed by this study. However, 
further studies are required to isolate the bioactive 
compounds and elucidate the precise mechanisms 
responsible for the antinociceptive activity.
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